<p>Sensus Healthcare, Inc.（纳斯达克代码：SRTS - 获取免费报告）首席执行官 Joseph Sardano 于 11 月 18 日星期二购买了 25,000 股该股票。每股平均购买成本为 4.03 美元，总价值为 100,750.00 美元。购买后，首席执行官在公司持有 1,200,293 股，价值为 4,837,180.79 美元。这代表其持股增加了 2.13%。该购买在向证券交易委员会的备案中披露，相关信息可通过此链接访问。</p>
<p>获取 <strong>Sensus Healthcare</strong> 的提醒：</p>
<h2>Sensus Healthcare 价格表现</h2>
<p>在周三的午盘交易中，SRTS 上涨了 0.03 美元，达到了 4.07 美元。该公司股票交易量为 48,211 股，而其平均交易量为 167,827 股。该公司的市值为 6678 万美元，市盈率为-68.00，贝塔值为 1.38。该股票的 50 日简单移动平均线为 3.42 美元，200 日简单移动平均线为 4.06 美元。Sensus Healthcare, Inc.的年内最低价为 3.03 美元，最高价为 9.33 美元。</p>
<p>Sensus Healthcare（纳斯达克代码：SRTS - 获取免费报告）最近一次公布季度财报是在 11 月 6 日星期四。公司报告本季度每股收益（EPS）为-0.06 美元，超出市场共识预期的-0.12 美元，超出幅度为 0.06 美元。Sensus Healthcare 的净利润率为-2.26%，股本回报率为-1.58%。本季度公司收入为 688 万美元，而分析师预期为 631 万美元。研究分析师平均预计 Sensus Healthcare, Inc.在当前年度将发布 0.32 美元的每股收益。</p>
<h2>机构资金流入和流出</h2>
<p>最近，一些大型投资者调整了对 SRTS 的持股。IFP Advisors Inc 在第一季度将其在 Sensus Healthcare 的持股增加了 37.2%。IFP Advisors Inc 目前持有 18,800 股该公司的股票，价值 89,000 美元，此前在该期间内又购买了 5,100 股。Kingstone Capital Partners Texas LLC 在第二季度收购了 Sensus Healthcare 的新股份，价值 317 万美元。Pacific Ridge Capital Partners LLC 在第一季度购买了 Sensus Healthcare 的新股份，价值约 542,000 美元。Acadian Asset Management LLC 在第一季度将其在 Sensus Healthcare 的持股增加了 35.3%。Acadian Asset Management LLC 目前持有 470,713 股该公司的股票，价值 2,225,000 美元，此前在上个季度又购买了 122,746 股。最后，纽约梅隆银行在第一季度将其在 Sensus Healthcare 的持股增加了 3.9%。纽约梅隆银行目前持有 141,971 股该公司的股票，价值 672,000 美元，此前在上个季度又购买了 5,289 股。目前，25.30% 的股票由机构投资者和对冲基金持有。</p>
<h2>分析师评级变动</h2>
<p>几家研究公司对 SRTS 进行了评估。华尔街 Zen 在 11 月 8 日星期六的报告中将 Sensus Healthcare 的评级从 “卖出” 上调至 “持有”。Zacks Research 在 10 月 22 日星期三的报告中将 Sensus Healthcare 的评级从 “强烈卖出” 上调至 “持有”。Lake Street Capital 在 8 月 8 日星期五的研究报告中将 Sensus Healthcare 的目标价从 13.00 美元下调至 6.00 美元，并对该公司给予 “买入” 评级。Weiss Ratings 在 10 月 8 日星期三的研究报告中重新发布了对 Sensus Healthcare 的 “卖出（d）” 评级。最后，HC Wainwright 在 8 月 12 日星期二的报告中将 Sensus Healthcare 的目标价从 12.00 美元下调至 8.00 美元，并对该公司给予 “买入” 评级。三位股票研究分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat，Sensus Healthcare 的共识评级为 “持有”，平均目标价为 8.00 美元。</p>
<p><strong>获取我们关于 Sensus Healthcare 的最新股票报告</strong></p>
<h2>Sensus Healthcare 公司简介</h2>
<p>（获取免费报告）</p>
<p>Sensus Healthcare, Inc.是一家医疗设备公司，向全球医疗服务提供者制造和销售放射治疗设备。该公司在其治疗设备组合中使用表面放射治疗，这是一种低能量 X 射线技术。它提供 SRT-100，这是一种光子 X 射线低能量表面放射治疗系统，为患者提供了一种替代手术的选择，用于治疗非黑色素瘤皮肤癌，包括基底细胞癌和鳞状细胞癌，以及其他皮肤病，如瘢痕疙瘩；以及 SRT-100 Vision，提供用户一个量身定制的表面放射治疗计划应用，集成了嵌入式高频超声成像模块、肿瘤体积分析、束边缘规划和剂量参数。</p>
<h2>推荐故事</h2>
<ul>
<li>我们更看好的五只股票比 Sensus Healthcare 更好</li>
<li>ETF 会支付股息吗？你需要知道的事情</li>
<li>3 只数据中心股票正在飙升——分析师认为其中 1 只可能会更高</li>
<li>什么是日经 225 指数？</li>
<li>为什么 GRAIL 股票可能是生物技术的下一个重大突破</li>
<li>3 只小盘股具有巨大的回报潜力</li>
<li>为什么福特与亚马逊的交易比你想象的更重要</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Sensus Healthcare 吗？</h2>
<p>在你考虑 Sensus Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐现在购买，以便在更广泛的市场注意到之前……而 Sensus Healthcare 并不在名单上。</p>
<p>虽然 Sensus Healthcare 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

Sensus医疗保健

<p>Sensus Healthcare 首席执行官 Joseph Sardano 以 100,750 美元购买了 25,000 股公司股票，使其持股比例增加了 2.13%。此次购买在 SEC 文件中披露。Sensus Healthcare 的股票表现包括 6678 万美元的市值，以及最近的季度财报显示收入为 688 万美元。分析师对该股票的评级不一，普遍评级为 “持有”，平均目标价格为 8.00 美元</p>

<p>Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) CEO Joseph Sardano purchased 25,000 shares of the stock in a transaction that occurred on Tuesday, November 18th. The stock was purchased at an average cost of $4.03 per share, with a total value of $100,750.00. Following the purchase, the chief executive officer owned 1,200,293 shares in the company, valued at $4,837,180.79. This represents a 2.13% increase in their position. The purchase was disclosed in a filing with the Securities &amp; Exchange Commission, which is accessible through this hyperlink.</p>
<div class="lb-trans"><p>Sensus Healthcare, Inc.（纳斯达克代码：SRTS - 获取免费报告）首席执行官 Joseph Sardano 于 11 月 18 日星期二购买了 25,000 股该股票。每股平均购买成本为 4.03 美元，总价值为 100,750.00 美元。购买后，首席执行官在公司持有 1,200,293 股，价值为 4,837,180.79 美元。这代表其持股增加了 2.13%。该购买在向证券交易委员会的备案中披露，相关信息可通过此链接访问。</p>
</div><p>Get <strong>Sensus Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Sensus Healthcare</strong> 的提醒：</p>
</div><h2>Sensus Healthcare Price Performance</h2>
<div class="lb-trans"><h2>Sensus Healthcare 价格表现</h2>
</div><p>SRTS traded up $0.03 during midday trading on Wednesday, hitting $4.07. 48,211 shares of the company's stock traded hands, compared to its average volume of 167,827. The company has a market cap of $66.78 million, a PE ratio of -68.00 and a beta of 1.38. The stock's fifty day simple moving average is $3.42 and its 200-day simple moving average is $4.06. Sensus Healthcare, Inc. has a one year low of $3.03 and a one year high of $9.33.</p>
<div class="lb-trans"><p>在周三的午盘交易中，SRTS 上涨了 0.03 美元，达到了 4.07 美元。该公司股票交易量为 48,211 股，而其平均交易量为 167,827 股。该公司的市值为 6678 万美元，市盈率为-68.00，贝塔值为 1.38。该股票的 50 日简单移动平均线为 3.42 美元，200 日简单移动平均线为 4.06 美元。Sensus Healthcare, Inc.的年内最低价为 3.03 美元，最高价为 9.33 美元。</p>
</div><p>Sensus Healthcare (NASDAQ:SRTS - Get Free Report) last announced its quarterly earnings results on Thursday, November 6th. The company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.12) by $0.06. Sensus Healthcare had a negative net margin of 2.26% and a negative return on equity of 1.58%. The company had revenue of $6.88 million for the quarter, compared to analyst estimates of $6.31 million. On average, research analysts expect that Sensus Healthcare, Inc. will post 0.32 EPS for the current year.</p>
<div class="lb-trans"><p>Sensus Healthcare（纳斯达克代码：SRTS - 获取免费报告）最近一次公布季度财报是在 11 月 6 日星期四。公司报告本季度每股收益（EPS）为-0.06 美元，超出市场共识预期的-0.12 美元，超出幅度为 0.06 美元。Sensus Healthcare 的净利润率为-2.26%，股本回报率为-1.58%。本季度公司收入为 688 万美元，而分析师预期为 631 万美元。研究分析师平均预计 Sensus Healthcare, Inc.在当前年度将发布 0.32 美元的每股收益。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of large investors have recently modified their holdings of SRTS. IFP Advisors Inc increased its position in Sensus Healthcare by 37.2% during the first quarter. IFP Advisors Inc now owns 18,800 shares of the company's stock worth $89,000 after acquiring an additional 5,100 shares during the period. Kingstone Capital Partners Texas LLC acquired a new stake in Sensus Healthcare in the 2nd quarter worth $3,170,000. Pacific Ridge Capital Partners LLC bought a new position in shares of Sensus Healthcare during the 1st quarter worth about $542,000. Acadian Asset Management LLC raised its position in shares of Sensus Healthcare by 35.3% during the first quarter. Acadian Asset Management LLC now owns 470,713 shares of the company's stock valued at $2,225,000 after buying an additional 122,746 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of Sensus Healthcare by 3.9% during the first quarter. Bank of New York Mellon Corp now owns 141,971 shares of the company's stock valued at $672,000 after buying an additional 5,289 shares during the last quarter. 25.30% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>最近，一些大型投资者调整了对 SRTS 的持股。IFP Advisors Inc 在第一季度将其在 Sensus Healthcare 的持股增加了 37.2%。IFP Advisors Inc 目前持有 18,800 股该公司的股票，价值 89,000 美元，此前在该期间内又购买了 5,100 股。Kingstone Capital Partners Texas LLC 在第二季度收购了 Sensus Healthcare 的新股份，价值 317 万美元。Pacific Ridge Capital Partners LLC 在第一季度购买了 Sensus Healthcare 的新股份，价值约 542,000 美元。Acadian Asset Management LLC 在第一季度将其在 Sensus Healthcare 的持股增加了 35.3%。Acadian Asset Management LLC 目前持有 470,713 股该公司的股票，价值 2,225,000 美元，此前在上个季度又购买了 122,746 股。最后，纽约梅隆银行在第一季度将其在 Sensus Healthcare 的持股增加了 3.9%。纽约梅隆银行目前持有 141,971 股该公司的股票，价值 672,000 美元，此前在上个季度又购买了 5,289 股。目前，25.30% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>Several research firms have weighed in on SRTS. Wall Street Zen upgraded Sensus Healthcare from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a report on Saturday, November 8th. Zacks Research upgraded Sensus Healthcare from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a report on Wednesday, October 22nd. Lake Street Capital decreased their target price on Sensus Healthcare from $13.00 to $6.00 and set a &#34;buy&#34; rating for the company in a research report on Friday, August 8th. Weiss Ratings reissued a &#34;sell (d)&#34; rating on shares of Sensus Healthcare in a research report on Wednesday, October 8th. Finally, HC Wainwright decreased their price objective on shares of Sensus Healthcare from $12.00 to $8.00 and set a &#34;buy&#34; rating for the company in a report on Tuesday, August 12th. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Sensus Healthcare has a consensus rating of &#34;Hold&#34; and an average target price of $8.00.</p>
<div class="lb-trans"><p>几家研究公司对 SRTS 进行了评估。华尔街 Zen 在 11 月 8 日星期六的报告中将 Sensus Healthcare 的评级从 “卖出” 上调至 “持有”。Zacks Research 在 10 月 22 日星期三的报告中将 Sensus Healthcare 的评级从 “强烈卖出” 上调至 “持有”。Lake Street Capital 在 8 月 8 日星期五的研究报告中将 Sensus Healthcare 的目标价从 13.00 美元下调至 6.00 美元，并对该公司给予 “买入” 评级。Weiss Ratings 在 10 月 8 日星期三的研究报告中重新发布了对 Sensus Healthcare 的 “卖出（d）” 评级。最后，HC Wainwright 在 8 月 12 日星期二的报告中将 Sensus Healthcare 的目标价从 12.00 美元下调至 8.00 美元，并对该公司给予 “买入” 评级。三位股票研究分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat，Sensus Healthcare 的共识评级为 “持有”，平均目标价为 8.00 美元。</p>
</div><p><strong>Get Our Latest Stock Report on Sensus Healthcare</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 Sensus Healthcare 的最新股票报告</strong></p>
</div><h2>Sensus Healthcare Company Profile</h2>
<div class="lb-trans"><h2>Sensus Healthcare 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.</p>
<div class="lb-trans"><p>Sensus Healthcare, Inc.是一家医疗设备公司，向全球医疗服务提供者制造和销售放射治疗设备。该公司在其治疗设备组合中使用表面放射治疗，这是一种低能量 X 射线技术。它提供 SRT-100，这是一种光子 X 射线低能量表面放射治疗系统，为患者提供了一种替代手术的选择，用于治疗非黑色素瘤皮肤癌，包括基底细胞癌和鳞状细胞癌，以及其他皮肤病，如瘢痕疙瘩；以及 SRT-100 Vision，提供用户一个量身定制的表面放射治疗计划应用，集成了嵌入式高频超声成像模块、肿瘤体积分析、束边缘规划和剂量参数。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Sensus Healthcare</li>
<li>Do ETFs Pay Dividends? What You Need to Know</li>
<li>3 Data Center Stocks Are Soaring—Analysts Think 1 Could Go Higher</li>
<li>What is the Nikkei 225 index?</li>
<li>Why GRAIL Stock Could Be Biotech’s Next Big Breakout</li>
<li>3 Small Caps With Big Return Potential</li>
<li>Why Ford's Deal With Amazon Is Bigger Than You Think</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Sensus Healthcare 更好</li>
<li>ETF 会支付股息吗？你需要知道的事情</li>
<li>3 只数据中心股票正在飙升——分析师认为其中 1 只可能会更高</li>
<li>什么是日经 225 指数？</li>
<li>为什么 GRAIL 股票可能是生物技术的下一个重大突破</li>
<li>3 只小盘股具有巨大的回报潜力</li>
<li>为什么福特与亚马逊的交易比你想象的更重要</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Sensus Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Sensus Healthcare 吗？</h2>
</div><p>Before you consider Sensus Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Sensus Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sensus Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐现在购买，以便在更广泛的市场注意到之前……而 Sensus Healthcare 并不在名单上。</p>
</div><p>While Sensus Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Sensus Healthcare 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Sensus 医疗保健（NASDAQ:SRTS）的首席执行官购买了价值 100,750.00 美元的股票